Synapse - Works

Results (3382)

TBCRC 018: Phase II study of iniparib plus chemotherapy to treat triple- negative breast cancer (TNBC) brain metastases (BM)

Meeting Abstract

Anders, C. K.; Nanda, R.; Liu, M. C.; Blackwell, K. L.; Van Poznak, C. H.; Abramson, V. G.; Storniolo, A. M.; Lin, N. U.; Stearns, V.; Melhem, A.; more...
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Phase II study of cixutumumab (IMC-A12, NSC742460; C) in hepatocellular carcinoma (HCC)

Meeting Abstract

Abou-Alfa, G. K.; Gansukh, B.; Chou, J. F.; Shia, J.; Capanu, M.; Kalin, M.; Chen, H. X.; Zojwalla, N. J.; Katz, S.; Reidy, D. L.; more...
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Phase I trial sunitinib plus everolimus in patients with metastatic renal cell carcinoma (mRCC)

Meeting Abstract

Molina, A. M.; Feldman, D. R.; Ginsberg, M. S.; Fischer, P.; Trinos, M. J.; Patil, S.; Motzer, R. J.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Use of comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys to investigate the role of nonmodifiable factors in determining ultimate renal function

Meeting Abstract

Lane, B. R.; Russo, P.; Uzzo, R.; Hernandez, A. V.; Boorjian, S. A.; Thompson, R. H.; Fergany, A. F.; Love, T.; Campbell, S.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

The Prostate Cancer Clinical Trials Consortium (PCCTC) bone scan data capture tool for clinical trials using Prostate Cancer Working Group 2 (PCWG2) criteria: Effect on data accuracy and workload

Meeting Abstract

Morris, M. J.; Farrelly, J. S.; Fox, J. J.; Dennis, E. R.; Schwartz, L. H.; Schoder, H.; Haupt, E. C.; Borwick, L. S.; Larson, S. M.; Scher, H. I.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Randomized phase II multicenter study of the efficacy and safety of sunitinib on the 4/2 versus continuous dosing schedule as first-line therapy of metastatic renal cell carcinoma: Renal EFFECT Trial

Meeting Abstract

Motzer, R. J.; Hutson, T. E.; Olsen, M. R.; Hudes, G. R.; Burke, J. M.; Edenfield, W. J.; Wilding, G.; Martell, B.; Hariharan, S.; Figlin, R. A.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

A phase III, randomized, controlled study to compare tivozanib with sorafenib in patients (pts) with advanced renal cell carcinoma (RCC)

Meeting Abstract

Motzer, R. J.; Bhargava, P.; Esteves, B.; Al-Adhami, M.; Slichenmyer, W.; Nosov, D.; Eisen, T.; Sternberg, C. N.; Hutson, T. E.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Phase II study of everolimus (RAD001) in metastatic transitional cell carcinoma (TCC) of the urothelium

Meeting Abstract

Milowsky, M. I.; Regazzi, A. M.; Garcia-Grossman, I. R.; Trout, A.; Flaherty, A.; Gerst, S.; Bajorin, D. F.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Hand-foot syndrome (HFS) as a potential biomarker of efficacy in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with sunitinib (SU)

Meeting Abstract

Michaelson, M. D.; Cohen, D. P.; Li, S.; Motzer, R. J.; Escudier, B.; Barrios, C. H.; Burnett, P. E.; Puzanov, I.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Effect of the novel anti-androgen ARN-509 on response and seizure in castration-resistant prostate cancer models

Meeting Abstract

Hager, J. H.; Smith, N. D.; Bischoff, E.; Jung, M. E.; Sawyers, C. L.; Heyman, R. A.; Rix, P. J.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save